Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1254
-
Total 13F shares, excl. options
-
141M
-
Shares change
-
-8.12M
-
Total reported value, excl. options
-
$14.2B
-
Value change
-
-$811M
-
Put/Call ratio
-
1.04
-
Number of buys
-
465
-
Number of sells
-
-507
-
Price
-
$100.97
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q4 2023
1,358 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q4 2023.
NOVARTIS AG - Ordinary Shares (NVS) has 1,254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141M shares
of 2.18B outstanding shares and own 6.46% of the company stock.
Largest 10 shareholders include Dodge & Cox (13.2M shares), PRIMECAP MANAGEMENT CO/CA/ (12.9M shares), MORGAN STANLEY (7.09M shares), DIMENSIONAL FUND ADVISORS LP (6.08M shares), LOOMIS SAYLES & CO L P (6.01M shares), FRANKLIN RESOURCES INC (5.91M shares), BANK OF AMERICA CORP /DE/ (5.15M shares), WELLINGTON MANAGEMENT GROUP LLP (4.75M shares), GOLDMAN SACHS GROUP INC (3.54M shares), and RENAISSANCE TECHNOLOGIES LLC (2.84M shares).
This table shows the top 1254 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.